Cargando…

Heterogeneous expression of the collagen receptor DDR1 in chronic lymphocytic leukaemia and correlation with progression

Detalles Bibliográficos
Autores principales:	Barisione, G, Fabbi, M, Cutrona, G, De Cecco, L, Zupo, S, Leitinger, B, Gentile, M, Manzoni, M, Neri, A, Morabito, F, Ferrarini, M, Ferrini, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301030/ https://www.ncbi.nlm.nih.gov/pubmed/28060374 http://dx.doi.org/10.1038/bcj.2016.121

Ejemplares similares

Cell-based Assay for Recruitment of DDR1 to Collagen-coated Beads
por: Juskaite, Victoria, et al.
Publicado: (2019)

Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients
por: Monti, Paola, et al.
Publicado: (2020)

Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells
por: De Cecco, Loris, et al.
Publicado: (2015)

Collagen induces activation of DDR1 through lateral dimer association and phosphorylation between dimers
por: Juskaite, Victoria, et al.
Publicado: (2017)

Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia
por: Maura, Francesco, et al.
Publicado: (2015)

Collagen binding specificity of the discoidin domain receptors: Binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1
por: Xu, Huifang, et al.
Publicado: (2011)

ADAM10 controls collagen signaling and cell migration on collagen by shedding the ectodomain of discoidin domain receptor 1 (DDR1)
por: Shitomi, Yasuyuki, et al.
Publicado: (2015)

lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome
por: Ronchetti, D, et al.
Publicado: (2016)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
por: Monti, Paola, et al.
Publicado: (2020)

Coupling of a specific photoreactive triple-helical peptide to crosslinked collagen films restores binding and activation of DDR2 and VWF
por: Malcor, Jean-Daniel, et al.
Publicado: (2018)

DDR1 autophosphorylation is a result of aggregation into dense clusters
por: Corcoran, David S., et al.
Publicado: (2019)

Phosphoproteomics of collagen receptor networks reveals SHP-2 phosphorylation downstream of wild-type DDR2 and its lung cancer mutants
por: Iwai, Leo K., et al.
Publicado: (2013)

Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia
por: Ronchetti, Domenica, et al.
Publicado: (2013)

Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts
por: Wasinski, Benjamin, et al.
Publicado: (2020)

Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy
por: Morabito, Fortunato, et al.
Publicado: (2023)

NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcome
por: Ronchetti, Domenica, et al.
Publicado: (2020)

DDR1 and Its Ligand, Collagen IV, Are Involved in In Vitro Oligodendrocyte Maturation
por: Silva, Maria Elena, et al.
Publicado: (2023)

MRIP Regulates the Myosin IIA Activity and DDR1 Function to Enable Collagen Tractional Remodeling
por: Coelho, Nuno M., et al.
Publicado: (2020)

IL-27 induces the expression of IDO and PD-L1 in human cancer cells
por: Carbotti, Grazia, et al.
Publicado: (2015)

Different Subcellular Localization of ALCAM Molecules in Neuroblastoma: Association with Relapse
por: Corrias, Maria Valeria, et al.
Publicado: (2010)

Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer
por: Terai, Hideki, et al.
Publicado: (2015)

Relevance of Stereotyped B-Cell Receptors in the Context of the Molecular, Cytogenetic and Clinical Features of Chronic Lymphocytic Leukemia
por: Maura, Francesco, et al.
Publicado: (2011)

To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients
por: Piszcz, Jaroslaw, et al.
Publicado: (2016)

Antitumor Effects of PRIMA-1 and PRIMA-1(Met) (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
por: Menichini, Paola, et al.
Publicado: (2021)

MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells
por: Matis, Serena, et al.
Publicado: (2022)

Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia
por: Morabito, Fortunato, et al.
Publicado: (2021)

Incorporation of DDR2 clusters into collagen matrix via integrin-dependent posterior remnant tethering
por: Li, Tingting, et al.
Publicado: (2018)

Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2
por: Slocum, Elizabeth, et al.
Publicado: (2019)

Mechanical Confinement and DDR1 Signaling Synergize to Regulate Collagen‐Induced Apoptosis in Rhabdomyosarcoma Cells
por: Gonzalez‐Molina, Jordi, et al.
Publicado: (2022)

New functions of DDR1 collagen receptor in tumor dormancy, immune exclusion and therapeutic resistance
por: Sirvent, Audrey, et al.
Publicado: (2022)

Lack of correlation between lymphocyte activating determinants and HLA-DR on acute leukaemias.
por: Taylor, G. M., et al.
Publicado: (1984)

Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
por: Freeman, Ciara L., et al.
Publicado: (2016)

A High Percentage of CD16+ Monocytes Correlates with the Extent of Bone Erosion in Chronic Lymphocytic Leukemia Patients: The Impact of Leukemic B Cells in Monocyte Differentiation and Osteoclast Maturation
por: Giannoni, Paolo, et al.
Publicado: (2022)

Collagen Induces a More Proliferative, Migratory and Chemoresistant Phenotype in Head and Neck Cancer via DDR1
por: Lai, Sook Ling, et al.
Publicado: (2019)

Rituximab for the treatment of patients with chronic lymphocytic leukemia
por: Gentile, M, et al.
Publicado: (2010)

Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia
por: Bagnara, Davide, et al.
Publicado: (2022)

Dual Roles of IL-27 in Cancer Biology and Immunotherapy
por: Fabbi, Marina, et al.
Publicado: (2017)

BMI1, ATM and DDR
por: Lin, Xiaozeng, et al.
Publicado: (2015)

Why Human Papillomaviruses Activate the DNA Damage Response (DDR) and How Cellular and Viral Replication Persists in the Presence of DDR Signaling
por: Bristol, Molly L., et al.
Publicado: (2017)

A Case of Lymphocytic Leukæmia
por: Reynolds, Fredrick H.
Publicado: (1933)

Cannot write session to /tmp/vufind_sessions/sess_6uvo1t5b4r1hdb5c4ge75cdoki